Research Fellow
Current- Developed PBPK models using MATLAB and SimBiology with mass-balanced ODEs to predict drug ADME and optimize nanoparticle (NP) therapeutic delivery systems, calibrating parameters with in vitro and in vivo pharmacology.
- Created mechanistic PK/PD models to simulate disease progression under immunotherapy, chemotherapy, and micro-RNA treatments, identifying 3 synergistic drug combinations and optimal dosing schedules for NSCLC.
- Conducted local and global sensitivity analyses, pinpointing key PBPK model parameters affecting drug biodistribution.
- Generated virtual populations via Latin Hypercube Sampling and Monte Carlo simulations to improve population-scale PK predictions.
- Translated preclinical PK data to human parameters using allometric scaling, evaluating clinical endpoints (e.g., PFS, OS), and optimizing dose regimens to enhance therapeutic efficacy.
- Utilized nonlinear mixed-effects modeling (popPK) with NONMEM to analyze inter-patient variability in drug concentrations from clinical data, informing clinical decision-making.